遗传性乳腺癌:综合风险评估和预防策略
Eliza Del Fiol Manna1, Davide Serrano2, Laura Cazzaniga2,3
1Division of Oncogenetics, Unimed Sorocaba, Sorocaba 18040-580, Brazil.
患有乳腺癌基因致病变异的女性患乳腺癌的风险更高,但透率不同. 个性化预防策略,包括改变生活方式和加强查,对于管理遗传性乳腺癌风险至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 预防医学 预防医学
背景情况:
- 中度到高透基因中的致病性/可能致病性 (P/LP) 变异会增加乳腺癌的风险.
- 这些变异的不完全透意味着不是每个人都会患上癌症,受各种因素的影响.
- 在了解基因组变异如何影响疾病呈现方面存在差距.
研究的目的:
- 审查当前文献中关于遗传性乳腺癌风险因素和预防策略的不一致性.
- 综合有关P/LP变体女性风险评估和预防的证据.
- 解决将基因组变异转化为表型呈现的局限性.
主要方法:
- 关于遗传性乳腺癌风险因素和预防的现有证据的文献综述.
- 综合有关风险评估,初级和二级预防策略的数据.
- 对中度和高透基因变异的不一致性进行分析.
主要成果:
- 大多数P/LP变体显示不完全透,受年龄,生活方式和其他因素的影响.
- 扩大基因测试可以识别更多具有P/LP变异的个体.
- 个性化风险评估是个性化预防的关键.
结论:
- 个性化风险评估和量身定制的预防干预措施对于患有P/LP变异的女性至关重要.
- 预防策略包括改变生活方式,化疗预防,加强监测和降低风险的手术.
- 需要进一步的研究来弥合基因组变异和临床表现之间的差距.
更多相关视频
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
相关概念视频
Cancer Prevention
Some...
Cancer Survival Analysis
Preventive Healthcare Services
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
